NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
WHO Guidelines for Pharmacological Management of Pandemic Influenza A(H1N1) 2009 and Other Influenza Viruses. Geneva: World Health Organization; 2010 Feb.
WHO Guidelines for Pharmacological Management of Pandemic Influenza A(H1N1) 2009 and Other Influenza Viruses.
Show detailsCertain patients with seasonal influenza virus infection or pandemic influenza (H1N1) 2009 virus infection are recognized to be at higher risk of developing severe or complicated illness. The Guidelines Panel did not review the evidence for the definition of these higher risk groups, but adopted, as the basis for treatment decisions in the context of these guidelines, the description developed through the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza4 as listed in Part I, Annex 1.
However, an important consideration in the management of influenza virus infections is that influenza virus infection in any patient can result in severe or complicated illness. This is particularly true for pandemic (H1N1) 2009 virus infection, in which about 1/3 of severely ill patients admitted to intensive care units were previously healthy persons not belonging to any known higher risk group.
Footnotes
- 4
Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. World Health Organization, November 2009. Available at: http://www
.who.int/csr /resources/publications /swineflu/clinical_management /en/index.html. Last accessed on 10 February 2010.
- Risk groups - WHO Guidelines for Pharmacological Management of Pandemic Influenz...Risk groups - WHO Guidelines for Pharmacological Management of Pandemic Influenza A(H1N1) 2009 and Other Influenza Viruses
Your browsing activity is empty.
Activity recording is turned off.
See more...